Morphic Medical Inc.: Clinical Trials

16 trials sponsored by Morphic Medical Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 terminated, 1 recruiting, 1 unknown. 8 Not applicable, 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 4, Terminated 2, Recruiting 1, Withdrawn 1
Phase 25Completed 5
Phase 11Completed 1

Follow Morphic Medical Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The RESET System Pivotal Clinical Trial (Protocol Revision K)
RESET Liner, Sham - Diabetes type2, Obesity
Not applicableRecruitingMorphic Medical Inc.2642019-09-092026-10-13
EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects
EndoBarrier SANS - Obesity, Type 2 Diabetes
Not applicableTerminatedMorphic Medical Inc.72015-05-012016-02-10
An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System
EndoBarrier - Type 2 Diabetes
Not applicableWithdrawnMorphic Medical Inc.2015-04-012016-09-14
EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve
Insertion of EndoBarrier for approximately one year - Obesity, Diabetes Mellitus
UnknownUniversitätsklinikum Hamburg-Eppendorf10002014-01-012017-06-23
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
EndoBarrier, Sham Procedure - Type 2 Diabetes, Obesity
Not applicableTerminatedMorphic Medical Inc.3252012-12-012017-02-01
Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity
EndoBarrier Gastrointestinal Liner - Type 2 Diabetes, Obesity
TerminatedMorphic Medical Inc.2442010-12-012017-03-07
Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner
EndoBarrier Gastrointestinal Liner - Type 2 Diabetes, Obesity
Not applicableCompletedMorphic Medical Inc.452010-10-012017-04-24
Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner
Endobarrier Liner - Obesity
Phase 2CompletedMorphic Medical Inc.192010-09-012017-02-15
Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study
EndoBarrier Liner - Type 2 Diabetes
Not applicableCompletedMorphic Medical Inc.232010-06-012017-02-17
Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity
EndoBarrier, Diet + Lifestyle Counseling - Type II Diabetes
Not applicableCompletedMorphic Medical Inc.772009-10-012016-10-03
A Pilot Trial of the EndoBarrier™ Flow Restrictor for Glycemic Improvement in Type 2 Diabetics
Type 2 Diabetes
CompletedMorphic Medical Inc.502009-09-012011-08-08
Study for Pre-Surgical Weight Loss in Type II Diabetes Patients
GI Liner - Type 2 Diabetes, Obesity
Phase 2CompletedMorphic Medical Inc.222008-10-012017-06-01
Study for Short Term Weight Loss in Candidates for Bariatric Surgery
Endobarrier Liner - Obesity
Phase 2CompletedMorphic Medical Inc.462008-10-012016-09-15
Multi-Center Pre-Bariatric Weight Loss Study
GI Sleeve Implantable weight loss device (EndoBarrier), Sham Procedure - Obesity
Phase 2CompletedMorphic Medical Inc.562007-06-012017-02-15
A Study of the GI Sleeve for the Treatment of Type 2 Diabetes
EndoBarrier Gastrointestinal Liner, Sham: endoscopy and standard of care - Type 2 Diabetes
Phase 1 / Phase 2CompletedMorphic Medical Inc.362007-01-012016-12-28
A Multicenter Study for Pre-Surgical Weight Loss
EndoBarrier Device, Diet & Lifestyle Counseling - Obesity
Not applicableCompletedMorphic Medical Inc.432007-01-012017-05-17

Conditions studied

Obesity (12)  ·  Diabetes Mellitus, Type 2 (11)  ·  Diabetes Mellitus (2)  ·  Weight Loss (2)

Interventions

Diet (2)  ·  salicylhydroxamic acid (2)  ·  Standard of Care (1)

Countries

Chile (3)  ·  United States (3)  ·  Brazil (2)  ·  Netherlands (2)  ·  Germany (1)  ·  Malaysia (1)  ·  United Kingdom (1)

Top investigators

Alex P Escalona, MD (2)  ·  Jan Willem Greve, MD (2)  ·  Keith Gersin, MD (2)  ·  Alex Escalona, MD (1)  ·  Christopher C Thompson, MD (1)  ·  Eng Hong Pok, MD (1)  ·  Jens Aberle (1)  ·  Julian Teare, MD (1)  ·  Lee M Kaplan, MD, PhD (1)  ·  Leonardo Rodriguez Grunert, MD (1)  ·  Michael Tarnoff, MD (1)  ·  Ricardo Cohen, MD (1)  ·  Wah Kheong Chan, MD (1)

Results publications

PMID 19858703, PMID 21932999, PMID 22534421, PMID 23920034, PMID 25072436, PMID 26446491, PMID 29504053